New insomnia pill shows promise in Late-Stage trial
Symptom relief
Completed
This study tested a new sleep medication called daridorexant in 164 adults and elderly people with insomnia. Participants received either the drug or a placebo for 4 weeks. Researchers measured changes in total sleep time, how fast they fell asleep, and time awake after sleep ons…
Phase: PHASE3 • Sponsor: Nxera Pharma Korea Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC